Exact Sciences (EXAS) Short Interest Ratio & Short Volume → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free EXAS Stock Alerts $42.93 -1.74 (-3.90%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Exact Sciences Short Interest DataCurrent Short Interest8,500,000 sharesPrevious Short Interest8,880,000 sharesChange Vs. Previous Month-4.28%Dollar Volume Sold Short$453.39 millionShort Interest Ratio2.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares184,530,000 sharesPercentage of Shares Shorted4.61%Today's Trading Volume1,632,300 sharesAverage Trading Volume2,561,695 sharesToday's Volume Vs. Average64% Short Selling Exact Sciences ? Sign up to receive the latest short interest report for Exact Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEXAS Short Interest Over TimeEXAS Days to Cover Over TimeEXAS Percentage of Float Shorted Over Time Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution Exact Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20248,500,000 shares $453.39 million -4.3%N/A2.9 $53.34 4/30/20248,880,000 shares $527.03 million -10.2%N/A3.6 $59.35 4/15/20249,890,000 shares $646.31 million +56.0%N/A4.1 $65.35 3/31/20246,340,000 shares $437.84 million -2.8%N/A2.8 $69.06 3/15/20246,520,000 shares $376.27 million -7.4%N/A3.4 $57.71 2/29/20247,040,000 shares $405.01 million -3.2%N/A3.6 $57.53 Get the Latest News and Ratings for EXAS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exact Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/20247,270,000 shares $444.12 million -0.3%N/A4 $61.09 1/31/20247,290,000 shares $476.77 million -4.1%N/A4.3 $65.40 1/15/20247,600,000 shares $510.11 million +1.3%N/A4.6 $67.12 12/31/20237,500,000 shares $554.85 million +5.8%N/A4.5 $73.98 12/15/20237,090,000 shares $467.23 million -3.5%N/A4.4 $65.90 11/30/20237,350,000 shares $470.40 million +0.8%N/A5.1 $64.00 11/15/20237,290,000 shares $460.14 million -3.7%N/A5.1 $63.12 10/31/20237,570,000 shares $466.24 million -7.3%N/A5.4 $61.59 10/15/20238,170,000 shares $533.26 million +7.8%N/A5.8 $65.27 9/30/20237,580,000 shares $517.11 million -11.7%N/A5.3 $68.22 9/15/20238,580,000 shares $657.91 million +0.4%N/A6.3 $76.68 8/31/20238,550,000 shares $715.38 million +1.9%N/A5.5 $83.67 8/15/20238,390,000 shares $721.71 million -2.9%N/A5.2 $86.02 7/31/20238,640,000 shares $842.75 million -4.4%N/A4.7 $97.54 7/15/20239,040,000 shares $875.70 million +1.8%N/A5.1 $96.87 6/30/20238,880,000 shares $833.83 million -13.0%N/A5 $93.90 6/15/202310,210,000 shares $953.51 million +8.9%N/A5.4 $93.39 5/31/20239,380,000 shares $765.22 million -4.4%N/A5 $81.58 5/15/20239,810,000 shares $793.92 million -11.7%N/A4.7 $80.93 4/30/202311,110,000 shares $711.82 million -3.2%N/A5.8 $64.07 4/15/202311,480,000 shares $766.75 million -2.7%N/A5.7 $66.79 3/31/202311,800,000 shares $800.16 million -4.7%N/A4.8 $67.81 3/15/202312,380,000 shares $796.78 million -5.3%N/A4.9 $64.36 2/28/202313,070,000 shares $814.65 million +18.2%N/A4.9 $62.33 2/15/202311,060,000 shares $731.51 million -7.0%N/A4.4 $66.14 1/31/202311,890,000 shares $802.81 million -7.5%N/A4.6 $67.52 1/15/202312,850,000 shares $886.14 million +11.8%N/A4.8 $68.96 12/30/202211,490,000 shares $568.87 million +15.1%N/A4.6 $49.51 12/15/20229,980,000 shares $445.21 million -1.4%N/A4.2 $44.61 11/30/202210,120,000 shares $454.89 million +2.0%N/A4.7 $44.95 11/15/20229,920,000 shares $439.26 million -2.6%N/A4.4 $44.28 10/31/202210,180,000 shares $354.06 million -4.1%N/A4.3 $34.78 10/15/202210,620,000 shares $322.32 million -9.2%N/A4.7 $30.35 9/30/202211,690,000 shares $379.81 million +4.2%N/A5.4 $32.49How Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. 9/15/202211,220,000 shares $458.79 million +14.0%N/A5.2 $40.89 8/31/20229,840,000 shares $349.81 million +4.5%N/A4.5 $35.55 8/15/20229,420,000 shares $416.74 million -2.9%N/A4.4 $44.24 7/31/20229,700,000 shares $437.47 million -9.7%N/A4.5 $45.10 7/15/202210,740,000 shares $503.71 million -3.1%N/A4.8 $46.90 6/30/202211,080,000 shares $436.44 million +1.3%N/A5 $39.39 6/15/202210,940,000 shares $423.27 million -5.2%N/A5 $38.69 5/31/202211,540,000 shares $574.81 million -14.6%N/A5.7 $49.81 5/15/202213,520,000 shares $706.96 million -0.5%N/A6.6 $52.29 4/30/202213,590,000 shares $748.13 million -4.2%N/A7.1 $55.05 4/15/202214,180,000 shares $987.07 million +3.1%N/A7.5 $69.61 3/31/202213,760,000 shares $962.10 million +1.8%N/A6.8 $69.92 3/15/202213,520,000 shares $778.21 million +5.0%N/A6.6 $57.56 2/28/202212,880,000 shares $1.01 billion +8.1%N/A6.2 $78.06 2/15/202211,920,000 shares $968.86 million -1.9%N/A5.6 $81.28 1/31/202212,150,000 shares $927.77 million +5.7%N/A6 $76.36 1/15/202211,500,000 shares $901.95 million +1.1%N/A5.7 $78.43 12/31/202111,370,000 shares $884.93 million -5.8%N/A6.6 $77.83 12/15/202112,070,000 shares $961.50 million -3.4%N/A7.5 $79.66 11/30/202112,500,000 shares $1.07 billion +4.2%N/A8.1 $85.37 11/15/202112,000,000 shares $1.08 billion +0.3%N/A8.3 $89.97 10/29/202111,960,000 shares $1.14 billion -6.2%N/A8.3 $95.22 10/15/202112,750,000 shares $1.26 billion +19.4%N/A9.2 $98.96 9/30/202110,680,000 shares $1.02 billion -1.6%N/A7.7 $95.45 9/15/202110,850,000 shares $1.14 billion +9.5%N/A8.3 $104.65 8/31/20219,910,000 shares $1.03 billion +6.0%N/A7.6 $104.38 8/13/20219,350,000 shares $868.99 million +3.7%N/A7 $92.94 7/30/20219,020,000 shares $972.72 million +1.5%N/A6.3 $107.84 7/15/20218,890,000 shares $989.99 million -4.7%N/A6.4 $111.36 6/30/20219,330,000 shares $1.16 billion -0.2%N/A6.6 $124.31 6/15/20219,350,000 shares $1.15 billion -0.6%N/A6.4 $122.57 5/28/20219,410,000 shares $1.04 billion +1.3%N/A6.3 $110.53 5/14/20219,290,000 shares $870.10 million -2.1%N/A5.8 $93.66 4/30/20219,490,000 shares $1.26 billion -2.5%N/A5.9 $133.02 4/15/20219,730,000 shares $1.24 billion +1.7%N/A6 $127.14 3/31/20219,570,000 shares $1.18 billion +8.1%N/A5.3 $123.65 3/15/20218,850,000 shares $1.14 billion +4.1%N/A4.9 $128.46 2/26/20218,500,000 shares $1.12 billion +1.0%N/A4.6 $131.30 2/12/20218,420,000 shares $1.24 billion -1.1%N/A4.7 $146.68 1/29/20218,510,000 shares $1.19 billion -9.0%N/A5.2 $139.55 1/15/20219,350,000 shares $1.38 billion -4.2%N/A4.6 $147.29 12/31/20209,760,000 shares $1.32 billion -7.7%N/A5.2 $135.40 12/15/202010,570,000 shares $1.37 billion -2.0%N/A4.9 $129.80 11/30/202010,780,000 shares $1.27 billion -8.5%N/A5 $118.19 11/15/202011,780,000 shares $1.45 billion +1.7%N/A5.5 $122.71 10/30/202011,580,000 shares $1.40 billion -9.7%N/A5.5 $120.51 10/15/202012,830,000 shares $1.33 billion -6.1%N/A7.4 $103.50 9/30/202013,660,000 shares $1.39 billion +8.2%N/A7.8 $101.95 9/15/202012,630,000 shares $966.07 million -4.1%N/A7.8 $76.49 8/31/202013,170,000 shares $991.57 million No ChangeN/A9.3 $75.29How Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. 8/14/202013,170,000 shares $1.12 billion +2.3%N/A10.1 $85.33 7/31/202012,870,000 shares $1.22 billion -2.9%N/A9.4 $94.75 7/15/202013,250,000 shares $1.23 billion -0.4%N/A9.3 $92.98 6/30/202013,300,000 shares $1.16 billion -6.9%N/A8.6 $86.94 6/15/202014,290,000 shares $1.27 billion +1.8%N/A8.5 $89.16 5/29/202014,040,000 shares $1.21 billion -4.0%N/A6.9 $85.88 5/15/202014,620,000 shares $1.26 billion +4.1%N/A5.9 $86.29 4/30/202014,040,000 shares $1.11 billion +0.8%N/A5.6 $78.98 4/15/202013,930,000 shares $930.80 million -4.1%N/A5.7 $66.82 3/31/202014,530,000 shares $1.10 billion +1.4%N/A5.4 $75.46 3/13/202014,328,900 shares $960.90 million -9.4%N/A4.1 $67.06 2/28/202015,820,000 shares $746.55 million +9.5%N/A6.7 $47.19 2/14/202014,450,000 shares $937.95 million -0.7%11.3%6.8 $64.91 1/31/202014,550,000 shares $1.18 billion -3.8%11.3%7.1 $80.76 1/15/202015,120,000 shares $1.43 billion +5.2%11.8%6.4 $94.83 12/31/201914,380,000 shares $1.29 billion +11.5%11.2%6.6 $89.57 EXAS Short Interest - Frequently Asked Questions What is Exact Sciences' current short interest? Short interest is the volume of Exact Sciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 8,500,000 shares of EXAS short. Learn More on Exact Sciences' current short interest. What is a good short interest ratio for Exact Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EXAS shares currently have a short interest ratio of 3.0. Learn More on Exact Sciences's short interest ratio. Which institutional investors are shorting Exact Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Exact Sciences: Walleye Trading LLC, Jane Street Group LLC, Torno Capital LLC, Twin Tree Management LP, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Exact Sciences' short interest increasing or decreasing? Exact Sciences saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 8,500,000 shares, a decrease of 4.3% from the previous total of 8,880,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Exact Sciences' short interest compare to its competitors? Here is how the short interest of companies compare to Exact Sciences: Charles River Laboratories International, Inc. (3.38%), Medpace Holdings, Inc. (3.54%), National Research Co. (1.73%), ICON Public Limited (2.31%), Biogen Inc. (2.41%), Alnylam Pharmaceuticals, Inc. (2.01%), BioMarin Pharmaceutical Inc. (1.97%), Neurocrine Biosciences, Inc. (1.85%), Incyte Co. (3.36%), United Therapeutics Co. (9.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Exact Sciences stock? Short selling EXAS is an investing strategy that aims to generate trading profit from Exact Sciences as its price is falling. EXAS shares are trading down $1.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Exact Sciences? A short squeeze for Exact Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EXAS, which in turn drives the price of the stock up even further. How often is Exact Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EXAS, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CRL Short Interest Data MEDP Short Interest Data NRC Short Interest Data ICLR Short Interest Data BIIB Short Interest Data ALNY Short Interest Data BMRN Short Interest Data NBIX Short Interest Data INCY Short Interest Data UTHR Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EXAS) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exact Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.